Haj Hasan Ahlam, Preet Gagan, Astakala Rishi Vachaspathy, Al-Adilah Hanan, Oluwabusola Emmanuel Tope, Ebel Rainer, Jaspars Marcel
Department of Chemistry, Marine Biodiscovery Centre, University of Aberdeen, Aberdeen, AB24 3UE UK.
Department of Medicinal Chemistry and Pharmacognosy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, 22110 Jordan.
In Silico Pharmacol. 2024 Aug 24;12(2):78. doi: 10.1007/s40203-024-00253-w. eCollection 2024.
Bovine mastitis is a worldwide disease affecting dairy cattle and causes major economic losses in the dairy industry. Recently, the emergence of microbial resistance to the current antibiotics complicates the treatment protocol which necessitates antibiotic stewardship and further research to find new active compounds. Recently, phytobiotics have gained interest in being used as an alternative to antibiotics in the poultry industry as an antibiotic stewardship intervention. This study evaluated the in vitro antibacterial activity of 16 flavonoids against bovine mastitis pathogens. Two flavones: 2-(4-methoxyphenyl)chromen-4-one () and 2-(3-hydroxyphenyl)chromen-4-one () showed inhibition of the growth of with MIC values range (25-50 µg mL) followed by a structure-activity relationship (SAR) study indicating that the presence of a hydroxyl group at C-3 or methoxy at C-4 increases the activity against while the presence of hydroxyl group at C-7 decreases the activity. Furthermore, a structure-based drug development approach was applied using several in silico tools to understand the interactions of active flavones at the active site of the DNA gyrase protein. Compound () showed a higher docking score than quercetin (standard) which is known to have antibacterial activity by inhibiting the DNA gyrase. In addition, the structure-based pharmacophores of compound () and quercetin showed similar pharmacophoric features and interactions with DNA gyrase. Based on our findings, compounds () and () are promising for further study as potential anti-microbial phytochemicals that can have a role in controlling bovine mastitis as well as to investigate their mechanism of action further.
The online version contains supplementary material available at 10.1007/s40203-024-00253-w.
牛乳腺炎是一种影响奶牛的全球性疾病,给乳制品行业造成重大经济损失。最近,微生物对现有抗生素产生耐药性,使治疗方案变得复杂,这就需要进行抗生素管理并进一步研究以寻找新的活性化合物。最近,植物源生物活性物质作为抗生素管理干预措施,在禽类行业中作为抗生素替代品的应用受到关注。本研究评估了16种黄酮类化合物对牛乳腺炎病原体的体外抗菌活性。两种黄酮:2-(4-甲氧基苯基)色原酮()和2-(3-羟基苯基)色原酮()对的生长有抑制作用,其最小抑菌浓度(MIC)值范围为(25 - 50 μg/mL),随后的构效关系(SAR)研究表明,C-3位存在羟基或C-4位存在甲氧基会增加对的活性,而C-7位存在羟基会降低活性。此外,使用多种计算机模拟工具应用基于结构的药物开发方法,以了解活性黄酮在DNA促旋酶蛋白活性位点的相互作用。化合物()显示出比已知通过抑制DNA促旋酶具有抗菌活性的槲皮素(标准品)更高的对接分数。此外,化合物()和槲皮素基于结构的药效团显示出相似的药效特征以及与DNA促旋酶的相互作用。基于我们的研究结果,化合物()和()有望作为潜在的抗微生物植物化学物质进行进一步研究,它们在控制牛乳腺炎方面可能发挥作用,并进一步研究其作用机制。
在线版本包含可在10.1007/s40203-024-00253-w获取的补充材料。